Schacht, Alexander

Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of Life

Wehmeier, P. M., Schacht, A., & Barkley, R. A. (2010) · Journal of Adolescent Health

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 628

Duloxetine and pregabalin: high-dose monotherapy or their combination? The “COMBO-DN study”–a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

Tesfaye, S., Wilhelm, S., Lledo, A., Schacht, A., Tölle, T., Bouhassira, D., Cruccu, G., Skljarevski, V., & Freynhagen, R. (2013) · Pain

Pain Mechanisms and TreatmentsPain Management and Treatment

Cited by 311

A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder

Harfterkamp, M., van de Loo-Neus, G., Minderaa, R. B., van der Gaag, R.-J., Escobar, R., Schacht, A., Pamulapati, S., Buitelaar, J. K., & Hoekstra, P. J. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 171

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever

Kluge, M., Schuld, A., Schacht, A., Himmerich, H., Dalal, M. A., Wehmeier, P. M., Hinze-Selch, D., Kraus, T., Dittmann, R. W., & Pollmächer, T. (2009) · Psychoneuroendocrinology

Schizophrenia research and treatmentTryptophan and brain disorders

Cited by 146

Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study

Bouhassira, D., Wilhelm, S., Schacht, A., Perrot, S., Kosek, E., Cruccu, G., Freynhagen, R., Tesfaye, S., Lledó, A., Choy, E., et al. (2014) · Pain

Pain Mechanisms and TreatmentsPain Management and Treatment

Cited by 132

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

Wehmeier, P. M., Schacht, A., Escobar, R., Savill, N., & Harpin, V. (2010) · Child and Adolescent Psychiatry and Mental Health

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 21

Treatment response for acute depression is not associated with number of previous episodes: Lack of evidence for a clinical staging model for major depressive disorder

Dodd, S., Berk, M., Kelin, K., Mancini, M., & Schacht, A. (2013) · Journal of Affective Disorders

Treatment of Major DepressionMental Health Treatment and Access

Cited by 20